117 Followers on Owler
Elcelyx is a developer of novel and re-positioning therapies for clinical developmental studies...
Read moreElcelyx is a developer of novel and re-positioning therapies for clinical developmental studies...
Read more
News
May 29, 2019
Business Wire
Press Release: Elcelyx Therapeutics : Anji Pharmaceuticals Acquires Late-Stage Clinical Asset and Readies for Ph3 Trials in Type 2 Diabetes with Chronic Kidney Disease
Oct 06, 2018
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Jul 31, 2018
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
Mar 20, 2018
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09032018 Prices from USD $250
Aug 02, 2017
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27072017 Prices from USD $250
Apr 05, 2017
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 16032017 Prices from USD $250
Nov 14, 2016
Drug Development Technology
Elcelyx Therapeutics:
Elcelyx Therapeutics reports positive Phase IIb study results of Metformin DR to treat type 2 diabetes
Nov 11, 2016
PharmaLeaders
Elcelyx Therapeutics: Elcelyx unveils positive results in phase 2b study of Metformin DR in type 2 diabetes
Oct 12, 2016
BioSpace
Elcelyx Therapeutics: Elcelyx Therapeutics Elects To Board Of Directors
May 25, 2016
BioSpace
Elcelyx Therapeutics: Elcelyx Therapeutics Completes Enrollment In Phase 2b Clinical Trial Of Metformin Delayed Release For Type 2 Diabetes
Looking for similar companies to Elcelyx Therapeutics?
Elcelyx Therapeutics News
Elcelyx Therapeutics Press Releases
Elcelyx Therapeutics Headquarters
Elcelyx Therapeutics Summary
ABOUT
Overview
Elcelyx is a developer of novel and re-positioning therapies for clinical developmental studies. Elcelyx Therapeutics was founded in 2009. Elcelyx Therapeutics' headquarters is located in San Diego, California, USA 92130. Elcelyx Therapeutics' Presid...CEO
Elcelyx Therapeutics's President & CEO, Alain D. Baron, currently has an approval rating of 79%. Elcelyx Therapeutics's primary competitors are Intarcia, XBiotech, Valeritas and 14 more.Website
elcelyx.comAcquisitions
There have been no acquisitions found related to Elcelyx TherapeuticsInvestments
Recent investment data cannot be found related to Elcelyx TherapeuticsFrequently Asked Questions about Elcelyx Therapeutics
When was Elcelyx Therapeutics founded?
Elcelyx Therapeutics was founded in 2009Who is Elcelyx Therapeutics's CEO?
Elcelyx Therapeutics's CEO is Alain D. BaronHow much revenue does Elcelyx Therapeutics generate?
Elcelyx Therapeutics generates $4.4M in revenueHow much funding does Elcelyx Therapeutics have?
Elcelyx Therapeutics has historically raised $93.3M in funding
Where is Elcelyx Therapeutics's headquarters?
Elcelyx Therapeutics's headquarters is in San Diego California, USAHow many employees does Elcelyx Therapeutics have?
Elcelyx Therapeutics has 40 employeesWhat sector does Elcelyx Therapeutics operate in?
Elcelyx Therapeutics is in Health Care ServicesWho are Elcelyx Therapeutics's competitors?
Elcelyx Therapeutics's top competitors are Intarcia, XBiotech, Valeritas